Deerfield Management Company, L.P. / SPRY
Deerfield Management Company, L.P.’s Ars Pharmaceuticals Inc Position
Does Deerfield Management Company, L.P. own Ars Pharmaceuticals Inc (SPRY)? Yes — 7.50M shares worth $60M (+0.71% of its 13F portfolio) as of Q1 2026.
Position Value
$60M
Q1 2026
Shares
7.50M
% of Portfolio
+0.71%
Quarters Held
14
currently held
Position History SPRY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.50M | $60M | +0.71% |
| Q4 2025 | 7.50M | $87M | +1.12% |
| Q3 2025 | 7.50M | $75M | +1.15% |
| Q2 2025 | 9.72M | $170M | +3.08% |
| Q1 2025 | 10.51M | $132M | +2.61% |
| Q4 2024 | 10.51M | $111M | +2.10% |
| Q3 2024 | 11.08M | $161M | +2.40% |
| Q2 2024 | 11.08M | $94M | +1.57% |
| Q1 2024 | 11.08M | $113M | +1.97% |
| Q4 2023 | 11.08M | $61M | +1.12% |
| Q3 2023 | 11.08M | $42M | +0.92% |
| Q2 2023 | 11.08M | $74M | +1.58% |
| Q1 2023 | 11.08M | $72M | +1.61% |
| Q4 2022 | 11.08M | $94M | +1.96% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deerfield Management Company, L.P.’s full portfolio or all institutional holders of SPRY.